Active substance
Cimetidine
- SFDA 6
- US FDA 58
- Health Canada 2
- US price lines 5
- NHS prices 5
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ADIATIN TAB 200MG | 200 mg | Tablet · Oral use | 60 Blister | SAR 30.05 | Generic · Prescription | FERRER INTERNATIONAL | Withdrawn by MAH · Not Marketed |
| CIMEDINE | 400 mg | Film-coated tablet · Oral use | 20 Blister | SAR 7.55 | Generic · Prescription | DAR ALDAWA | Withdrawn by MAH · Not Marketed |
| CIMEDINE | 200 mg | Film-coated tablet · Oral use | 24 Blister | SAR 19.15 | Generic · Prescription | DAR ALDAWA | Withdrawn by MAH · Not Marketed |
| CITIUS TAB 200MG | 200 mg | Tablet · Oral use | 60 Blister | SAR 27.05 | Generic · Prescription | ALMIRALL PRODES PHARMA S.A. | Withdrawn by MAH · Not Marketed |
| DYSPAMET SUSP 200MG-5ML | 40 mg/ml | Oral suspension · Oral use | 1 Bottle | SAR 33.20 | NCE · Prescription | SMIITHKLINE BEECHAM | Withdrawn by MAH · Not Marketed |
| TAGAMET TABLETS 400 MG. | 400 mg | Tablet · Oral use | 20 Blister | SAR 46.85 | NCE · Prescription | SMIITHKLINE BEECHAM | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CIMETIDINE | 200MG; 300MG; 400MG | tablet · oral | TEVA | Prescription | 17 May 1994 |
| CIMETIDINE | 200MG; 300MG; 400MG; 800MG | tablet · oral | MYLAN | Prescription | 17 May 1994 |
| CIMETIDINE | 800MG; 200MG; 300MG; 400MG | tablet · oral | CHARTWELL MOLECULES | Prescription | 17 May 1994 |
| CIMETIDINE | 800MG | tablet · oral | TEVA | Prescription | 17 May 1994 |
| CIMETIDINE HYDROCHLORIDE | EQ 300MG BASE/5ML | solution · oral | CHARTWELL MOLECULAR | Prescription | 22 Dec 1994 |
| TAGAMET HB | 200MG | tablet · oral | MEDTECH PRODUCTS | Over-the-counter | 19 Jun 1995 |
| CIMETIDINE HYDROCHLORIDE | EQ 300MG BASE/5ML | solution · oral | PAI HOLDINGS PHARM | Prescription | 28 Oct 1997 |
| CIMETIDINE | 200MG | tablet · oral | L PERRIGO CO | Over-the-counter | 29 Oct 1998 |
| CIMETIDINE | 200MG; 300MG; 400MG; 800MG | tablet · oral | BIONPHARMA | Prescription | 7 Nov 2024 |
| CIMETIDINE | 200MG; 300MG; 400MG; 800MG | tablet · oral | AUROBINDO PHARMA LTD | Prescription | 12 Nov 2024 |
| TAGAMET | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | GLAXOSMITHKLINE | Discontinued | 16 Aug 1977 |
| TAGAMET | EQ 300MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution · oral | GLAXOSMITHKLINE | Discontinued | 16 Aug 1977 |
| TAGAMET | EQ 300MG BASE/2ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | GLAXOSMITHKLINE | Discontinued | 16 Aug 1977 |
| TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | EQ 6MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | GLAXOSMITHKLINE | Discontinued | 31 Oct 1985 |
| CIMETIDINE HYDROCHLORIDE | EQ 300MG BASE/5ML | solution · oral | G AND W LABS INC | Discontinued | 1 Jun 1994 |
| CIMETIDINE HYDROCHLORIDE | EQ 300MG BASE/2ML | injectable · injection | PH HEALTH | Discontinued | 31 Aug 1994 |
| CIMETIDINE HYDROCHLORIDE | EQ 300MG BASE/2ML | injectable · injection | LUITPOLD | Discontinued | 20 Dec 1994 |
| CIMETIDINE | 300MG; 400MG | tablet · oral | CYCLE | Discontinued | 23 Dec 1994 |
| CIMETIDINE | 800MG | tablet · oral | CYCLE | Discontinued | 23 Dec 1994 |
| CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | EQ 6MG BASE/ML | injectable · injection | HOSPIRA | Discontinued | 27 Dec 1994 |
| CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | EQ 360MG BASE/100ML; EQ 480MG BASE/100ML; EQ 180MG BASE/100ML; EQ 240MG BASE/100ML; EQ 90MG BASE/100ML; EQ 120MG BASE/100ML | injectable · injection | HOSPIRA | Discontinued | 29 Dec 1994 |
| CIMETIDINE | 200MG; 300MG; 400MG; 800MG | tablet · oral | CHARTWELL RX | Discontinued | 31 Jan 1995 |
| CIMETIDINE HYDROCHLORIDE | EQ 300MG BASE/2ML | injectable · injection | HOSPIRA | Discontinued | 31 Jan 1995 |
| CIMETIDINE HYDROCHLORIDE | EQ 300MG BASE/2ML | injectable · injection | HOSPIRA | Discontinued | 31 Jan 1995 |
| CIMETIDINE HYDROCHLORIDE | EQ 300MG BASE/2ML | injectable · injection | HOSPIRA | Discontinued | 31 Jan 1995 |
33 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| CIMETIDINE | 00487872 | 300 MG | TABLET · ORAL | AA PHARMA INC |
| CIMETIDINE | 00584215 | 200 MG | TABLET · ORAL | AA PHARMA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CIMETIDINE 200 MG TABLET | $0.20417 | per EA | 23 Sep 2026 |
| US NADAC | CIMETIDINE 300 MG TABLET | $0.23584 | per EA | 23 Sep 2026 |
| US NADAC | CIMETIDINE 300 MG/5 ML SOLN | $0.60019 | per ML | 23 Sep 2026 |
| US NADAC | CIMETIDINE 400 MG TABLET | $0.31934 | per EA | 23 Sep 2026 |
| US NADAC | CIMETIDINE 800 MG TABLET | $0.72081 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Cimetidine 200mg tablets | £6.45 | 60 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Cimetidine 200mg/5ml oral solution | £28.49 | 600 ml | 1 Oct 2026 |
| NHS Drug Tariff | Cimetidine 200mg/5ml oral solution sugar free | £48.75 | 300 ml | 1 Oct 2026 |
| NHS Drug Tariff | Cimetidine 400mg tablets | £6.65 | 60 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Cimetidine 800mg tablets | £21.00 | 30 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 26 Mar 2019 TAGAMET HB — safety-related labeling change
Labeling sections changed: Warnings and Precautions
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.